CDKN2A and cervical carcinoma: In cervical cancer cells, the lack of ANRIL expression increases p15 levels but does not influence the expression of p16 or alternative reading frame (ARF) and leads to cell-cycle arrest at the G2/M phase, resulting in suppression of proliferation [104].